Human Factors Validation of a Wearable, On-Body Infusor for Subcutaneous Administration of Furosemide
{{output}}
Purpose: Furoscix® (subcutaneous furosemide) is administered using a wearable On-Body Infusor (OBI) and is approved for the treatment of congestion associated with heart failure (HF). The purpose of this study was to assess the ... ...
